Cite

Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer.

MLA

Eilertsen, Ina A., et al. “Technical Differences between Sequencing and Microarray Platforms Impact Transcriptomic Subtyping of Colorectal Cancer.” Cancer Letters, vol. 469, Jan. 2020, pp. 246–55. EBSCOhost, https://doi.org/10.1016/j.canlet.2019.10.040.



APA

Eilertsen, I. A., Moosavi, S. H., Strømme, J. M., Nesbakken, A., Johannessen, B., Lothe, R. A., & Sveen, A. (2020). Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer. Cancer Letters, 469, 246–255. https://doi.org/10.1016/j.canlet.2019.10.040



Chicago

Eilertsen, Ina A, Seyed H Moosavi, Jonas M Strømme, Arild Nesbakken, Bjarne Johannessen, Ragnhild A Lothe, and Anita Sveen. 2020. “Technical Differences between Sequencing and Microarray Platforms Impact Transcriptomic Subtyping of Colorectal Cancer.” Cancer Letters 469 (January): 246–55. doi:10.1016/j.canlet.2019.10.040.